This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers in Ohio say oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines. Using RT-PCR and western blotting to interrogate the consequences of oncostatin M and IL-6 stimulation in osteosarcoma cells, the researchers found that the oncostatin receptor is expressed by all human osteosarcoma cells lines, and that treatment of the cell lines with the oncostatin "induced phosphorylation of STAT3, Src, and JAK2.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.